The efficacy and safety of antidepressants in inflammatory arthritis: A Cochrane systematic review

Journal of Rheumatology

Volumn 39, Issue SUPPL. 90, 2012, Pages 21-27

  Richards, Bethan L ^a   Whittle, Samuel L ^b   Van Der Heijde, Désirée M ^c   Buchbinder, Rachelle ^d,e  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CABRINI HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Ankylosing spondylitis; Antidepressant; Rheumatoid arthritis; Systematic review

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DEXTROPROPOXYPHENE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOSULEPIN; IBUPROFEN; IMIPRAMINE; INDOMETACIN; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; ANALGESIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ANKYLOSING SPONDYLITIS; ARTHRITIS; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPOTENSION; INFLAMMATORY ARTHRITIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEROTONIN SYNDROME; SHORT COURSE THERAPY; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREMOR; XEROSTOMIA; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; EVIDENCE BASED MEDICINE; EXPERT WITNESS; INTERNATIONAL COOPERATION; METHODOLOGY; PATHOPHYSIOLOGY;

ANALGESICS; ANTIDEPRESSIVE AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; HUMANS; INTERNATIONAL COOPERATION; PAIN; PAIN MANAGEMENT;

EID: 84865835215     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120338     Document Type: Review

References (31)

1. Kvien T. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004;22 Suppl 1:1-12.
2. Skevington S. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain 1998;76:395-406.
3. Cooper RG BC, Spanswick CC. What is pain management, and what is its relevance to the rheumatologist? Rheumatology 2003;42:1133-7.
4. Kuipers R. Imipramine in the treatment of rheumatic patients. Acta Rheumatol Scand 1962;8:45-51.
5. Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: A meta-analysis. JAMA 2009;301:198-209.
6. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007;4:CD005454.
7. Urquhart DM, Hoving JL, Assendelft WW, Roland M, van Tulder MW. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev 2008;1:CD001703.
8. Watson C. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994;9:392-405.
9. Lynch M. Antidepressants as analgesics: A review of randomized controlled trials. J Psychiatry Neurosci 2001;26:30-6.
10. Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001;26:21-9.
11. Su X, Gebhart GF. Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon. Pain 1998;76:105-14.
12. Nicholson GM, Blanche T, Mansfield K, Tran Y. Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs. Eur J Pharmacol 2002;452:35-48.
13. Reynolds IJ, Miller RJ. Tricyclic antidepressants block N-methyl-D-aspartate receptors: Similarities to the action of zinc. Br J Pharmacol 1988;95:95-102.
14. Baba H, Kohno T, Moore KA, Woolf CJ. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 2001;21:1750-6.
15. Marino F, Cosentino M, Bombelli R, Ferrari M, Lecchini S, Frigo G. Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells. Exp Hematol 1999;27:489-95.
16. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000;52:595-638.
17. Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 1999;42:2561-8.
18. Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology 2012 Mar 24. [Epub ahead of print]
19. Richards BL, Whittle SL, Buchbinder R. Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2011;11:CD008920.
20. Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.0.2 (updated September 2009): The Cochrane Collaboration; 2009.
21. Sackett DL, Richardson WS, Rosenberg WM, Haynes RB. Evidence-based medicine: How to practice and teach EBM. London, UK: Churchill Livingstone; 1997.
22. Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta-analyses. Ch 9. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Cochrane Book Series. Chichester, UK: John Wiley & Sons, Ltd. 2008.
23. Ash G, Dickens CM, Creed FH, Jayson MI, Tomenson B. The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology 1999;38:959-67.
24. Bird H, Broggini M. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: A randomized, double blind, parallel group study. J Rheumatol 2000;27:2791-7.
25. Fowler PD, MacNeill A, Spencer D, Robinson ET, Dick WC. Imipramine, rheumatoid arthritis and rheumatoid factor. Curr Med Res Opin 1977;5:241-6.
26. Frank RG, Kashani JH, Parker JC, Beck NC, Brownlee-Duffeck M, Elliott TR, et al. Antidepressant analgesia in rheumatoid arthritis. J Rheumatol 1988;15:1632-8.
27. Grace EM, Bellamy N, Kassam Y, Buchanan WW. Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Curr Med Res Opin 1985;9:426-9.
28. Macfarlane JG, Jalali S, Grace EM. Trimipramine in rheumatoid arthritis: A randomized double-blind trial in relieving pain and joint tenderness. Curr Med Res Opin 1986;10:89-93.
29. Saarialho-Kere U, Julkunen H, Mattila MJ, Seppala T. Psychomotor performance of patients with rheumatoid arthritis: Cross-over comparison of dextropropoxyphene, dextropropoxyphene plus amitriptyline, indomethacin, and placebo. Pharmacol Toxicol 1988;63:286-92.
30. Sarzi Puttini P, Cazzola M, Boccassini L, Ciniselli G, Santandrea S, Caruso I, et al. A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J Int Med Res 1988;16:331-7.
31. Koh WH, Pande I, Samuels A, Jones SD, Calin A. Low dose amitriptyline in ankylosing spondylitis: A short term, double blind, placebo controlled study. J Rheumatol 1997;24:2158-61.